Supportive therapy in multiple myeloma

Recent Results Cancer Res. 2011:183:307-33. doi: 10.1007/978-3-540-85772-3_15.

Abstract

In this chapter we want to give an overview on various supportive measures, which help to prevent or to fight complications of multiple myeloma, improve patient wellbeing and increase safety of administration of specific anti-myeloma therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anemia / etiology
  • Anemia / prevention & control
  • Anemia / therapy*
  • Blood Transfusion
  • Bone Diseases / etiology
  • Bone Diseases / prevention & control
  • Bone Diseases / therapy*
  • Calcitonin / therapeutic use
  • Clodronic Acid / adverse effects
  • Clodronic Acid / therapeutic use
  • Diphosphonates / adverse effects
  • Diphosphonates / therapeutic use
  • Erythropoietin / therapeutic use
  • Fractures, Bone / etiology
  • Fractures, Bone / prevention & control
  • Fractures, Bone / therapy
  • Hematinics
  • Humans
  • Hypercalcemia / etiology
  • Hypercalcemia / therapy
  • Imidazoles / adverse effects
  • Imidazoles / therapeutic use
  • Multiple Myeloma / complications*
  • Multiple Myeloma / therapy*
  • Osteoporosis / etiology
  • Osteoporosis / prevention & control
  • Osteoporosis / therapy
  • Pamidronate
  • Recombinant Proteins
  • Renal Insufficiency / etiology
  • Renal Insufficiency / prevention & control
  • Renal Insufficiency / therapy
  • Zoledronic Acid

Substances

  • Diphosphonates
  • Hematinics
  • Imidazoles
  • Recombinant Proteins
  • Clodronic Acid
  • Erythropoietin
  • Zoledronic Acid
  • Calcitonin
  • Pamidronate